Two Italian companies, Bio-on and Sadam Group, has begun working on a project to develop innovative industrial processes, at competitive cost and with low environmental impact, to produce levulinic acid, a key element of the sustainable chemical industry of the future.
Bio-on, the Italian industrial biotech company, will begin producing its own special biopolymers at a new 1,000 tons/year plant to be completed in 2017 with an investment of €15 million. To announce this was Marco Astorri, chairman and Ceo of Bio-on S.p.A. who outlined to the financial community the new 2017-2020 industrial plan last week. Bio-on will manage to revive an abandoned manufactory site of Granarolo, an Italian food company which operates oin the fresh milk and dairy-cheese sector, dry pasta, deli meats and vegetable foods.
Bioplastics which are made from renewable waste plant sources, with no competition with food supply chains, and are 100% naturally biodegradable. The final phase testing Minerv PHA Supertoys for making scale models has begun, launched by Bio-on in collaboration with Italeri, the leading manufacturer of static models. The results will be presented in February 2017 in Nuremberg, Germany during the “Play and toys fair”, the sector’s largest and most prestigious event.
The cutting-edge bio-plastic Minerv-PHA developed by Bio-on is now available in the prestigious database “Materials Library” of Material ConneXion, the world’s largest resource for innovative and sustainable materials and processes. This resource, both as a physical samples library and an online searchable database, with thousands of references, aims to collect only the most interesting materials from the point of view of innovation, technical characteristics and possible application.
Bio-on, an Italian industrial biotech company, yesterday announced a major result achieved thanks to its new collaboration with Tampere University of Technology Finland, one of the most important centers in the world for research and innovation in the use of paper and plastic for food packaging. “A joint project launched in 2015 has produced for the very first time tetrapak type containers made of a combination of paper and bioplastic, namely the special grade EC (Extrusion Coating) of the Minerv PHA biopolymer”.
Italian biotech company Bio-on announces the launch of a new collaboration with Italeri S.p.A., a production and distribution leader in the modelling sector. Thanks to this agreement, the manufacture of scale models will be done for the first time with the special grade Minerv PHA Supertoys, the new type of bioplastic developed by Bio-on laboratories.
Bio-on and SECI Spa, part of Gruppo Industriale Maccaferri holding, signed an agreement to build the world’s first facility for the production of PHAs bioplastic from biodiesel production co-products, namely glycerol. The two companies will work together to build a production site with a 5 thousand tons/year output, expandable to 10 thousand tons/year.
Bio-on and Moore Capital signed a license agreement to build the first Brazil-based facility to produce PHAs bioplastic from sugar cane co-products.
The two companies, operating in sustainable biochemistry and in the development of eco-sustainable industrial solutions, will work together to build a production site with a 10 thousand tons/year output, in the state of São Paulo and/or Acre State.
An agreement signed yesterday by Italian biotech company Bio-on and Cristal Union will see France’s first facility for the production of PHAs bioplastic from sugar beet co-products.
The two companies, operating in sustainable biochemistry and sugar, alcohol and bioethanol production, will work together to build a production site with a 5 thousand tons/year output, expandable to 10 thousand tons/year.
With the bioplastic developed by Bio-on, it is now possible to create capsules for controlled drug administration inside the human body or for gradual release of active substances in agriculture. The properties of MINERV PHA bioplastic, completely “biobased” and 100% naturally biodegradable, enable the creation of micro and nano particles, both full and hollow, in which the trapped active substance is released gradually, even after months, exploiting the biodegradability of bioplastic. In this way, it is possible to administer directly in the human body numerous types of drugs such as anaesthetics, antibiotics, anti-inflammatories, antitumor, hormones, steroids and vaccines. Cosmetic or agricultural use is equally broad.